Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Blood Adv · 2025 · PMC12166372 · PMID 40127395

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = .08so close (0.05 < p ≤ 0.1)

Lower disease burden at infusion was associated with improved OS compared to high disease burden (HR, 0.23; 95% CI, 0.06-0.86; P = .03) and trended toward improved RFS although this did not reach statistical significance (HR, 0.47; 95% CI, 0.20-1.10; P = .08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.